Tag: dialysis
Aperto® DCB: A breakthrough in prolonging dialysis access survival
This advertorial is sponsored by Cardionovum.
Cardionovum’s CE-marked Aperto drug-coated balloon (DCB) is, according to expert opinion and a growing evidence base, spearheading a revolution...
Pathfinder Medical and Imperial College London awarded Innovate UK Smart grant...
Pathfinder Medical has been awarded a Smart grant for a £1.1 million (US$1.4 million) project by Innovate UK, the UK's innovation agency. A press...
Aperto® drug-coated balloon technology shows promise in dialysis access patients
This advertorial is sponsored by Cardionovum®.
The Aperto drug-coated balloon (DCB) technology (Cardionovum) is “one of the very promising new technologies” for treating central vein stenosis...
Gore acquires InnAVasc Medical
Gore has announced the acquisition of InnAVasc Medical, a privately held medical technology company focused on advancing care for patients with end-stage renal disease...
Artivion initiates enrolment in PERSEVERE clinical trial
Artivion announced today that it has initiated enrolment in the PERSEVERE clinical trial to determine if patients with an acute DeBakey Type I aortic...
Intraoperative vascular mapping during haemodialysis access “should be incorporated into routine...
Intraoperative ultrasonographic venous mapping is a useful tool to evaluate vessel suitability for arteriovenous fistula (AVF) creation, Yana Etkin (Zucker School of Medicine at...
VentureMed completes enrolment of Flex Vessel Prep system randomised controlled trial...
VentureMed Group recently announced that it has completed enrolment of a randomised controlled trial (RCT) titled 'Flex Vessel Prep prior to PTA for the...
Case report: Aspirex™S enables treatment of thrombosed prosthetic arteriovenous grafts
This advertorial, sponsored by BD, is only available in selected countries and geographies.
“Percutaneous mechanical thrombectomy debulks thrombus load, leading to rapid revascularisation for...
Dialysis tech firm Pathfinder Medical secures £8.5 million
Pathfinder Medical, which has developed a proprietary technology to guide and accurately align catheters in endovascular procedures allowing clinicians to make connections across blood...
Alio and Lifeline create partnership for dialysis access patient monitoring
Alio has announced a partnership with Lifeline Vascular Care in support of patients living with end-stage renal disease (ESRD). Alio leverages artificial intelligence (AI)...
New survey finds one third of UK dialysis patients still not...
Quanta Dialysis Technologies announced today the results of the UK Dialysis Patient Experience Survey, showing the wide variance in care experienced by UK dialysis...
The WavelinQ™ EndoAVF System takes an innovative approach in creating endovascular...
NOTE: This advertorial is ONLY available to watch in selected countries and geographies
This advertorial, sponsored by BD, is intended for readers in the...
Stable incidence and survival of AVFs in Danish dialysis population in...
Despite an older dialysis population, the proportion and survival of arteriovenous fistulas (AVFs) in Danish dialysis patients has not changed over a 39-year period....
Study provides new insights on COVID-19 risk in patients receiving dialysis
Many individuals with kidney failure have been unable to self-isolate during the COVID-19 pandemic because they require dialysis treatments in clinics several times a...
More mixed results for DCBs in AV access maintenance as evidence...
Additional randomised controlled data regarding the effectiveness of drug-coated balloons (DCBs) in maintaining arteriovenous (AV) access offers new evidence, but it is freighted with...
Wearable device for AV fistula remote monitoring shows promise—but faces commercial...
A new wearable device designed to remotely monitor arteriovenous (AV) fistulae function in dialysis access patients uncovered promising data leading one set of researchers...
Tunnelled dialysis catheter insertions without fluoroscopy deemed safe and effective in...
“The technique of inserting tunnelled dialysis catheters (TDCs) in the right internal jugular vein without fluoroscopy is a safe and effective method in selected...
Renal artery involvement in EVAR linked to permanent dialysis and lower...
Renal artery involvement (RAI) in endovascular aneurysm repair (EVAR) is “highly predictive of the need for postoperative and permanent dialysis,” Anastasia Plotkin (University of...
VasQ external support awarded NUB Status 1 reimbursement renewal for 2021...
The German Institute for Hospital Remuneration (InEK) has renewed the new examination and treatment methods (NUB) Status 1 designation of VasQ external support (Laminate...
UK-first innovation could save lives of dialysis patients
Barts Health NHS Trust has performed a UK-first operation outside of trial setting that could reduce mortality and risks of infection in patients with...
National Kidney Foundation releases guideline for vascular access in dialysis patients
The American Journal of Kidney Diseases (AJKD) has published the National Kidney Foundation's KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update, a completely...
No increased short- to midterm mortality among dialysis access patients treated...
A systematic review and meta-analysis, recently published in the Journal of Endovascular Therapy, found no difference in short- to midterm mortality among patients who...
GraftWorx launches evaluation of remote monitoring solution for dialysis patients
GraftWorx has commenced a service evaluation in collaboration with the Academic Health Science Network (AHSN) and a National Health Service (NHS) Hospital Foundation Trust...
The dialysis access landscape in 2018: Challenges, advances and future directions
Guidelines of the European Society for Vascular Surgery1 give an overview of the current best evidence for vascular access for dialysis. Although these guidelines...
Current status on drug-eluting devices in dialysis access
Dialysis access fistulae and grafts are life-saving in patients with renal insufficiency and failure. Numbers of patients requiring haemodialysis have continued to rise over...
VasQ series at Berlin’s Charité University Hospital produces “exceptionally promising results”
As part of the main scientific programme at Dreiländertagung 2016 (4–8 October, Bern Switzerland), Peter Olschewski has reported “exceptionally promising results” from the first...
